NCT00290030View on ClinicalTrials.gov

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Prostatic HyperplasiaAcute Urinary Retention
Interventions
DRUG

Alfuzosin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY